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Abstract
Background: Objectively assessed physical performance is a strong predictor for morbidity and premature death
and there is an increasing interest in the role of sarcopenia in many chronic diseases. There is a need for robust
and valid functional tests in clinical practice. Therefore, the repeatability and validity of a newly developed maximal
step up test (MST) was assessed.
Methods: The MST, assessing maximal step-up height (MSH) in 3-cm increments, was evaluated in 60 healthy
middle-aged subjects, 30 women and 30 men. The repeatability of MSH and the correlation between MSH and
isokinetic knee extension peak torque (IKEPT), self-reported physical function (SF-36, PF), patient demographics and
self-reported physical activity were investigated.
Results: The repeatability between occasions and between testers was 6 cm. MSH (range 12-45 cm) was
significantly correlated to IKEPT, (r = 0.68, P < 0.001), SF-36 PF score, (r = 0.29, P = 0.03), sex, age, weight and BMI.
The results also show that MSH above 32 cm discriminates subjects in our study with no limitation in self-reported
physical function.
Conclusions: The standardised MST is considered a reliable leg function test for clinical practice. The MSH was
related to knee extension strength and self-reported physical function. The precision of the MST for identification
of limitations in physical function needs further investigation.
Background
Primary health care handles patients of all ages for
whom increased physical activity and improved physical
function would be valuable to prevent and treat com-
mon chronic diseases [1-4]. Objectively assessed physical
performance-e.g. low maximal oxygen uptake [5-7] or
low muscle strength [8,9]-is a strong predictor of mor-
bidity and premature death independent of physical
activity and muscle mass. Interestingly, in men < 60
years the rate of loss of strength has been shown to be
more important than actual strength [10]. Muscle
strength provides a better estimate of mortality risk than
does muscle quantity [11]. Recent evidence-based
recommendations include endurance as well as resis-
tance training [3] for health benefits. Loss of muscle
mass and knee extensor strength correlates with an
increased risk of falling and loss of functional indepen-
dence, and has been identified as the most important
factor limiting the ability to rise from a chair [12].
Finally, quadriceps muscle weakness is a primary risk
factor for knee pain, disability, and progression of joint
damage in persons with osteoarthritis (OA) of the knee
[13], one of the most common medical conditions from
midlife onwards [13,14].
One way of assessing a patient’s leg muscle strength is
to gauge the ability to step up. Leg function has been
tested by having the patient mount an ordinary platform
with five levels: step height correlated to muscle
strength in older people [15,16] and patients with knee
and hip OA [17]. In contrast, assessment of middle-aged
meniscectomised patients based on a footstool climbing
test with few levels did not provide acceptable results
when test-retest and floor/ceiling effects were taken into
account [18]. Although, there are several tests assessing
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assessment tools [19,20], a systematic review concluded
that no single tool can be recommended for implemen-
tation in all settings or for all subpopulations within
each setting [21]. Many tools for the assessment of fall
risk prevention among older adults have been previously
studied. We sought to evaluate an assessment tool suita-
ble for all ages by being differentiating and difficult
enough to perform also for young and middle-aged per-
sons. The test for leg strength and leg function in this
study was developed in order to be a standardised pro-
cedure suitable for clinical daily use.
Standardisation, done in the first author’s clinical prac-
tice, started with assessing patients’ ability to step up on
one or two ordinary stairway steps. This only discrimi-
nated for 18 and 36 cm. Therefore a maximal step-up test
(MST) with 3-cm intervals between step heights was
developed for assessment of maximal step-up height
(MSH). The rationale for choosing 3-cm intervals was: 1.
to have enough levels for discrimination between subjects/
patients and test occasions, 2. to have sufficiently few
levels not to exhaust subjects/patients and 3. to be able to
come as close as possible to the highest individual MSH
while taking 1 and 2 into consideration. In our study the
highest step height reached with the standardised MST is
denoted the “maximal step-up height” (MSH).
Accordingly, the overall aims were to evaluate a new
method for measurement of lower-extremity function,
the standardised MST, by assessing: 1. MSH repeatabil-
ity, 2. MSH relation to isokinetic knee extension peak
torque (IKEPT), health-related quality of life (SF-36,
subscales for physical function (PF), bodily pain (BP)
and general health (GH)), individual characteristics and
self-reported physical activity (the International Physical
Activity Questionnaires, IPAQ, short form) and 3. MSH
cut-off for limitations in physical function (SF-36, PF).
Methods
Subjects
The study was performed at Karolina Primary Health Care
Center in Karlskoga (Örebro County Council, Sweden), a
town with 30 000 inhabitants in a rural district. Inclusion
criteria were: 1) female or male, 2) 30-65 years old, 3) no
self-reported complaints associated with the legs or hips
leading to a visit to a health care unit in the previous six
months, 4) no major health problems that interfered with
climbing stairs, 5) from inactive to regularly physically
active, 6) never before having been tested with a step-up
test, climbing test or on an isokinetic device, 7) well moti-
vated, and 8) understanding Swedish. Invitations were dis-
tributed to workplaces, a men’s running group and their
wives. Thirty women and 30 men with a median (range)
age of 53 (34-63) and 55 (36-64) years, respectively
( t a b l e1 )w e r ee n r o l l e d .T h ef e m a l ea n dm a l es u b j e c t s
came from about 20 different work-places, respectively:
They represented a wide variety of professions and educa-
tional backgrounds. Written informed consent was
obtained from all participants after oral and written infor-
mation was provided. The local ethics committee at
Örebro County Council approved all procedures.
Design
Subjects were invited in groups of ten on two test occa-
sions (occ 1 and occ 2), one week between occasions,
for intra-examiner assessment of MSH test-retest
repeatability. Four weeks after occ 1, the participants
came individually to the third test occasion (occ 3) for
assessment of IKEPT and MSH test-retest repeatability
(comparing occ 1 and occ 3). At occ 1 and occ 2, MSH
was assessed twice at least 30 minutes apart, by two
examiners-the first author and a tester accustomed to
the MST-in random order for assessment of inter-exam-
iner test-retest repeatability. MSH of both legs was
assessed with the MST on all three occasions. The MST
values remained secret between examiners and occa-
sions, and the subjects agreed not to inform the tester
of earlier results. Weight and height were measured at
occ 1, and weight at occ 3. The SF-36 was assessed at
occ 1. Physical activity level during the week between
occ 1 and occ 2 and the week before occ 3 was assessed.
The subjects were instructed to maintain their ordinary
physical activity habits during the study. At occ 3 all
subjects began with a MST conducted by the first
author. Thirty minutes later, IKEPT was measured by a
physiotherapist well acquainted with the procedure.
Measurements and equipment
The MSH (cm) in both legs was assessed, in 3-cm incre-
ments, with the standardised MST method (see
Table 1 Descriptive statistics of subjects for age,
anthropometry, self-reported energy expenditure and
scores on the health-related quality of life scale SF-36, by
sex
Women, n =
30
Men, n =
30
Total, n =
60
Descriptive statistics at
baseline
Mean (SD) Mean (SD) Mean (SD)
Age (years) 52.6 (7.0) 55.3 (6.2) 54.0 (6.7)
Weight (kg) 71.9 (11.2) 86.1 (11.3) 79.0 (13.2)
Height (cm) 166.1 (4.8) 177.9 (5.4) 172.0 (7.8)
Body mass index, BMI, (kg·
m
-2)
26.1 (4.0) 27.3 (4.2) 26.7 (4.1)
Energy expenditure, (kcal·wk
-
1)
925 (722) 1469
(1249)
1123 (344)
PF, Physical function 91.0 (10.6) 96.3 (4.5) 93.6 (8.5)
BP, Bodily pain 76.6 (24.2) 84.0 (20.0) 80.3 (22.3)
GH, General health 79.1 (20.4) 79.5 (18.0) 79.3 (19.1)
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(the step-up box, SB) shown in Figure 1. IKEPT (N·m,
60°·sec
-1), essentially reflecting maximal concentric
quadriceps strength, was assessed in an isokinetic
dynamometer (Biodex System III PRO, Biodex Medical
S y s t e m ,N e wY o r k ,N Y ,U S A ) .B o d yw e i g h tw a sm e a -
sured in light clothing without shoes to the nearest 0.1
kg using an electronic balance (Seca model). Height was
measured without shoes to the nearest 0.5 cm using a
scale fixed to the wall. BMI was calculated according to
standard practice (kg· m
-2). A locally adapted version of
the self-administered International Physical Activity
Questionnaire (IPAQ) “t h el a s t7d a y ss h o r tf o r mq u e s -
tionnaire” [22], was used for assessing self-reported phy-
sical activity (min·wk
-1). Energy expenditure (kcal·wk
-1)
was calculated according to the MET (Metabolic
Equivalent) estimates [23]. Mean energy expenditure
from reported vigorous and moderate activity, and
strength training time over a two-week period, was used.
To assess self-reported health-related quality of life,
the Swedish version of the SF-36 was used [24]. The
subscales physical function (PF), bodily pain (BP) and
general health (GH) shown in table 1, all with a strong
correlation to age [25], were used to describe subjects
and to compare them with the general Swedish popula-
tion. The values in the subscales range from 0 to 100.
Values < 100 imply restrictions in function. The PF sub-
scale items 3a-3j, and our selection of items 3a, b, d, f
and g (table 2) assumed by the authors in this study to
be suitable for assessment of healthy subjects, were used
for comparison with the first assessment of MSH (mean
of right and left leg) at occ 1. This scale was also used
to investigate whether any MSH score cut-off level iden-
tified subjects with any limitation (score < 100) in physi-
cal function.
Testing procedures
The MSH was assessed with the standardised MST in
the step-up device as described in Figure 1. The infor-
mation provided to the examiner including how to
instruct and encourage the subject performing the stan-
dardised MST is presented in detail in Appendix 1. The
step-up test was performed in ordinary clothes, with
bare feet or with socks. To avoid undesirable side effects
of the MST, an incremental height increase was recom-
mended. After the step-up demonstration the examiner
asked if the subject had any current or previous pro-
blems with leg function, joint pain, and instability or
muscle weakness. A low step height was selected for
familiarisation with the test procedure. The tester super-
vised and approved the MST on one or both legs and
the subject was then told to try a higher level. Three
attempts at the highest level for each leg were allowed.
The subjects were given verbal encouragement to per-
form at their best.
The third test occasion began with a MST of each leg
followed by twenty minutes of seated rest, during which
the physiotherapist described the IKEPT test. The sub-
ject had a 5-min warm-up on a bicycle before being
placed in a sitting position in the Biodex device with a
90° flexion in the knee and hip. The manufacturer’s
standard test protocol was followed. An angular velocity
of 60°·sec
-1 was chosen because it has been estimated to
approximate that used when climbing ordinary stairs
[26], and would not exhaust the subject. The subjects
were given verbal encouragement and visual feedback to
perform at their best.
Statistics
Primary outcome variable for this study was MSH where
the mean of right and left leg was used. Data from the
f i r s ta n dt h es e c o n d ,a n df r o mt h ef i r s ta n dt h et h i r d
test occasions, were analysed using a repeated measures
ANOVA to estimate the within-subject standard devia-
tion for further calculation of the test-retest repeatabil-
ity, which is 2.77 times the within-subject standard
deviation [27]. We expect 95%o fd i f f e r e n c e sb e t w e e n
paired observations, i.e. test occasions, to be less than
this definition of a repeatability adopted by the British
Standards Institution [27,28]. MST at occ 3 was used to
assess the relation to demographic factors such as sex,
age, weight, body height, and BMI using multiple linear
regressions. The validity of the MSH was investigated by
analysing the relation between MSH at occ 3 and mean
IKEPT of the right and left leg, using the Pearson
Figure 1 The standardised maximal step-up test (MST)-
instructions to subject. First picture: after start position seen in the
first picture, “go up as high as possible on the floor foot, stand still
and find your balance”. Second picture: “look forward and straighten
your back while moving your body weight over to the step-up leg,
stand still and again find your balance” as seen in the second
picture. Third picture: “start the step-up by pressing the step-up foot
into the board while extending in your knee, and during a slight
bending forward slowly step-up onto the board”. Fourth picture:
end position with both feet on the board. After approved step-up
test try a higher level, the highest approved level is the maximal
step-up height for each leg.
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to the SF-36 subscales using the Pearson correlation
coefficient. Logistic regression was used to determine
whether MSH could discriminate a cut-off score for any
limitation (numerically < 100) or no limitation (= 100)
in SF-36, PF. A cut-off level was estimated where the
odds ratio for any limitation was set to 1.0. Subse-
quently, the cut-off level observed was used to compare
predicted values against observed values. The measures
of sensitivity, specificity and likelihood ratio were calcu-
lated to address the potential for MSH to discriminate
subjects with any limitation in SF-36, PF. All tests were
two-sided and P < 0.05 was regarded as statistically sig-
nificant. Statistica, v8, StatSoft Inc, Tulsa, OK, USA, was
used for statistical calculations.
Results
Characteristics of the study population
The characteristics of the subjects and scores on the SF-36
subscales are presented in table 1. The mean BMI indicates
that both women and men were overweight. Energy expen-
diture data indicate moderate physical activity among men
and less among women. Both sexes included subjects ran-
ging from inactive to moderate active, who match patients
likely to present in primary care for referral for physical
activity on prescription [29], and to elite trained and conse-
quently with a wide range of calculated energy expenditure.
Assessment of SF-36 showed that our subjects had
marginally better PF and BP, and about the same GH as
the general Swedish population [25]. In our study 58.3%
(34-64 years) had at least one limitation in PF, compared
with 60.6% (35-64 years) in the general Swedish population
[25]. Our subjects thus appear representative for the mid-
dle-aged general population in Sweden. The numbers of
limitations observed in the domain of PF are presented in
table 2. Nearly all limitations reported by our subjects were
found in items 3a, b, d, f and g. Older subjects and women
reported more limitations. The MSH range was 12-45 cm
for women and 18-45 cm for men. The mean (SD) maxi-
mal step-up heights (cm) for each leg for all assessments at
occasions 1, 2 and 3 are presented in table 3. The differ-
ences between legs and assessments were minor.
Repeatability
The intra-examiner test-retest (one week between occa-
sions) showed MSH repeatability of 6.9 and 5.9 cm for
right and left leg, respectively. When four weeks passed
between the first and third occasion the corresponding
figures were 5.0 and 4.9 cm. The inter-examiner (mini-
mum 30 minutes) repeatability was 9.6 and 8.5 cm (occ
1), and 6.6 and 5.6 cm (occ 2), for the right and the left
leg, respectively.
Correlations
MSH was correlated to IKEPT (r =0 . 6 8 ,P <0 . 0 0 1 )( F i g -
ure 2), to SF-36, PF score (r =0 . 2 9 ,P =0 . 0 3 )a n d
Table 2 Frequency of subjects with various degrees of limitation in physical function according to the items in SF-36,
i.e., yes, limited a lot; yes, limited a little; no, not limited at all
SF-36, Physical Function Severely limited Somewhat limited Not limited
Subgroup Item Total (Women/Men) Total (Women/Men) Total (Women/Men)
n = 60 (30/30) n = 60 (30/30) n = 60 (30/30)
3a vigorous activities 7 (6/1) 22 (10/12) 31 (14/17)
3b moderate activities 0 (0/0) 6 (5/1) 54 (25/29)
3d climbing several flights of stairs 0 (0/0) 3 (2/1) 57 (28/29)
3f bending, kneeling, or stooping 0 (0/0) 13 (8/5) 47 (22/25)
3g walking more than 2 km 0 (0/0) 2 (2/0) 58 (28/30)
Table 3 Descriptive statistics using mean and SD for the maximal step-up height (MSH) in subjects at occasion 1 to 3
Total, n = 60 Women, n = 30 Men, n = 30
Occasion Leg Right Left Right Left Right Left
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Occasion 1
First assessment 31.3 (5.8) 31.2 (4.9) 28.1 (4.9) 28.7 (4.2) 34.4 (4.9) 33.6 (4.3)
Second assessment 31.7 (5.8) 31.5 (5.0) 28.4 (4.8) 28.7 (4.1) 35.0 (4.7) 34.2 (4.4)
Occasion 2
First assessment 32.2 (5.3) 31.8 (4.9) 29.0 (5.1) 29.0 (4.6) 35.3 (3.3) 34.4 (3.7)
Second assessment 31.7 (5.9) 31.3 (5.3) 27.9 (5.4) 27.9 (4.4) 35.3 (3.8) 34.6 (3.9)
Occasion 3
Assessment 32.1 (5.4) 32.1 (5.0) 28.9 (4.4) 28.8 (3.9) 35.3 (4.2) 35.3 (3.6)
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-0.30, P = 0.02). MSH was not correlated to BP (r =0 . 0 8 ,
P = 0.53) and GH (r = 0.02, P = 0.88) scores of the SF-36.
Regression analysis
The correlation of MSH to subject characteristics and
self-reported physical activity is presented in table 4.
Both models revealed significant inverse correlations.
The first model revealed significantly lower MSH among
women, and lower MSH with increasing age and BMI.
The second model showed significantly lower MSH
among women, and with increasing age and higher
weight. Body height and self-reported physical activity
did not significantly correlate to MSH. Results from the
logistic regression modelling showed that MSH at the
first test occasion could discriminate limitations in phy-
sical functioning, OR = 1.13, P = 0.037, and a corre-
sponding cut-off level at 34 cm. The model had a
sensitivity of 71% and a specificity of 58%. Subgroup cal-
culations showed a cut-off level of 32 cm for women
and 35 cm for men which discriminated those reporting
any limitation in SF-36, PF. There were 7 out of 30
women and 14 out of 30 men having MSH > 32 cm and
> 35 cm, respectively, on both legs.
Leg problems and injuries (> 6 months before study)
reported by the subjects could explain lower MSH and
IKEPT values as well as low values in PF scores. The
subjects did not report any adverse effects of the study
and there were no dropouts. Performing the MST took
5-15 minutes and IKEPT took 25-30 minutes.
Discussion
T h i ss t u d ys h o w st h a tt h eM S Ti sar o b u s t ,s a f ea n d
relevant test for leg strength and leg function in a
healthy middle-aged population. Compared to IKEPT
we rated MST as a fast test. The subjects limitations in
physical function, their low to moderate energy expendi-
ture and mean BMI > 25, indicated that many of the
subjects in our study would be suitable candidates for a
physical activity prescription when they present them-
selves in primary health care.
The measure of repeatability for this standardised
MST indicates that 95% of all differences between occa-
sions should be less than 6 cm. Larger differences are to
be considered as “true”, reliable individual changes. If
MSH was assessed with increments of 1 cm the preci-
sion would probably be even better. Further, systematic
changes on a group level, i.e. differences between or
within groups, may be detected at a much lower level
than 6 cm.
Figure 2 Correlation between maximal step-up height and
quadriceps strength. Relation between the maximal step-up
height (MSH, cm) and the quadriceps strength (isokinetic knee
extension peak torque, IKEPT, N·m, 60°·sec
-1) at occasion 3. Values
for step-up height and quadriceps strength are calculated as the
mean of the right and left leg.
Table 4 Results of regression coefficient and its corresponding standard error, P-value and R
2, for variables correlated
to the outcome variable MSH, after using multiple linear regressions
Estimate B (SE) Estimate of standardised B (SE) P-value R
2
Model 1 0.598
Intercept 54.46 (4.07) < 0.001
Sex (Women = 1, Men = 0) -7.34 (0.86) -0.74 (0.09) < 0.001
Age (years) -0.16 (0.07) -0.22 (0.09) 0.020
Body mass index, BMI, (kg·m
-2) -0.38 (0.11) -0.31 (0.09) 0.001
Model 2 0.594
Intercept 40.77 (16.35) 0.016
Sex (Women = 1, Men = 0) -7.76 (1.41) -0.78 (0.15) < 0.001
Age (years) -0.17 (0.07) -0.22 (0.09) 0.020
Height (cm) 0.08 (0.09) 0.13 (0.14) 0.341
Weight (kg) -0.13 (0.04) -0.35 (0.11) 0.002
Mean energy expenditure (kcal·wk
-1) 0.00002 (0.0004) 0.0037 (0.09) 0.967
Two different models are presented, using two different measures for body composition, model 1 uses BMI, and model 2 uses height and weight.
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step up to a high level (39-45 cm). Their quadriceps
strength assessed by IKEPT was high and they had
lower BMI, good joint mobility, coordination and bal-
ance, and reported no or tolerable pain. At this highest
level the femur was parallel to the floor, and the knee
angle was about 90° at the starting position for the
step-up leg. For these subjects, this is probably the
highest theoretical individual MSH with our
standardisation.
The lower inter-tester difference between MSH at
occasion 2 compared to occasion 1 could reflect a tester
and/or subject learning effect. The threshold for maxi-
mum expected intra- and inter-tester differences in
MSH in our study was 6 cm, which is less than the 10-
cm interval used by other researchers when correlating
step height to significant changes in leg strength and
function [16,17,26]. Future studies are needed to further
investigate the clinical significance of the 6 cm
repeatability.
While not intending to predict knee-extension peak
torque from MSH values, this study showed a significant
correlation between MSH and IKEPT. This study indi-
cates that MST is a valid test for knee extension func-
tion and less time-consuming. IKEPT values, used in
our study as the gold standard, are highly reliable, and
no learning effect has been observed [30]. Earlier results
in two studies investigating the correlation between the
maximum rising strength from sitting and isometric
knee extension strength show correlations comparable
to those in the present study [31,32]. Furthermore, MST
assesses leg strength and performance in functional
positions and movements and does not require expen-
sive equipment as does IKEPT measurements.
We also found a significant correlation between MSH
and SF-36, PF. Therefore, the standardised MST could
be useful both to identify consequences of sarcopenia
[33] and to support follow-up of treatment. Further stu-
dies are needed to investigate the effects of prescribed
physical activity [34] on an individual’s MSH, most likely
corresponding to changes in knee extension function
and self-reported physical function. In studies with older
community dwelling populations objective measures of
physical capability are predictors of all cause mortality
[35].
On speculation, we explored whether a MSH cut-off
value could identify perceived limitation of physical
function and found cut-off values of >32 cm (women)
and >35 cm (men) on group level. This might be of use
for clinical assessment of the risk of falling or loss of
functional independence in the future. Studies on larger
groups of patients and comparisons with healthy sub-
jects are needed before any further conclusions can be
made.
We present MSH correlations to sex, age and demo-
graphics in two models with multiple linear regressions
(table 4) indicating that the MST can be a useful tool
for lifestyle interventions. In model 1, when BMI was
used in the same model as weight and height were sepa-
rately included, no correlations could be detected for
height. The lack of correlation between MSH and body
height in model 2, also found by other researchers
investigating step height [15], could be due to the rela-
tively small size of the study. The MSH did not correlate
to self-reported physical activity. Objective estimates of
physical activity [36] might have yielded lower values
and a different activity pattern, possibly with lower
variability. If so, a correlation between MSH and physi-
cal activity might have been identified.
Conclusions
In clinical practice, objective measurements of physical
function are seldom used and routines are generally not
in place. The MST-assessing MSH on each leg-repre-
sents one aspect of current individual leg function, and
is most likely dependent on leg muscle strength, but
also on mobility, coordination, joint stability, balance
and the degree of pain.
In conclusion, the maximal step-up test is simple to
conduct, requires little equipment and space and can be
performed by subjects in everyday clothing. We suggest
that the maximal step-up test could be a useful and
valid test of leg muscle strength and physical function
and could be integrated into ordinary clinical routines.
Appendix 1
Title: The standardised maximal step-up test (MST)
assessing maximal step-up height (MSH)
Description: Detailed instructions to the examiner
and to the subject
I. Begin with your demonstration of the MST at a low
level, i.e. corresponding to an ordinary stair height. The
step-up is done in ordinary cloths, with bare feet or
with socks. To avoid any undesirable side effects an
incremental increase of heights is recommended.
II. During the step-up demonstration, carefully explain
the rules for the approved MST:
i) the foot of the step-up leg should be put in a place
where good balance is established
ii) the arms should hang vertically at the sides
iii) stand in an upright position
iv) move slowly while performing the step-up
v) the pelvis should remain in a central position dur-
ing the step-up
vi) avoid kicking off from the floor with the floor foot
vii) tilting backward or forward, or bending forward
with the face passing the vertical line from patella, is
not allowed.
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Page 6 of 8III. After the demonstration ask the subject if there
are any current or previous problems with leg function,
joint pain or muscle weakness. Select a level at a low
step height for training, and start with what the subject
considers the strongest or dominant leg, to obtain famil-
iarity with the test procedure. Then choose a MST start
level at which the subject feels certain of being able to
perform the test procedure in full compliance with the
instructions. The subject is asked to start the MSH
assessment with the leg suspected to be the weakest. If
not approved MST try a lower level as the start level.
IV. Examiners instructions to the subjects during the
MST (figure 1):
First: i) at starting position put the floor foot 5-10 cm
in front of the step-up device, and put the step-up foot
onto the board, ii) finish starting position by going up
as high as possible on the toes of the floor foot, stand
still and find your balance.
Second: look straight ahead and straighten your back
while moving your body weight over to the step-up leg
on the board in the step-up device, stand still and again
find your balance.
Third: start the step-up by pressing the step-up foot
into the board while extending in your knee, and during
a slight bending forward slowly step-up onto the board.
Fourth: slowly put the floor foot onto the board in the
step-up device and the MST is finished.
V. The examiner supervises and approves the MST on
one or both legs and the subject is then told to try a
higher level. Three attempts at the highest level for each
leg are allowed. The subjects are given verbal encour-
agement to perform at their best. The highest approved
level is the maximal step-up height for each leg.
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